Anti-Human RXFP1 Therapeutic Antibody (22DA23)

Ask supplier a question | View on supplier's website

Recombinant monoclonal antibody 22DA23 is a mouse monoclonal antibody that specifically binds to human LGR7 and can be potentially used in the treatment of cancers such as ovarian cancer.

Supplier	Creative Biolabs
Product #	TAB-0661CL
Pricing	Inquiry
Applications	ELISA, FC
Host	Mouse
Target	LGR7 (Relaxin/insulin-like family peptide receptor 1)

Feedback